Opioid overdoses involving xylazine in emergency department patients: a multicenter study

J. S. LOVE ; M. LEVINE ; K. ALDY ; J. BRENT ; A. J. KROTULSKI ; B. K. LOGAN ; C. VARGAS-TORRES ; S. E. WALTON ; A. AMADUCCI ; D. CALELLO ; R. HENDRICKSON ; A. HUGHES ; A. KURT ; B. JUDGE ; A. PIZON ; E. SCHWARZ ; J. SHULMAN ; T. WIEGAN ; P. WAX ; A. F. MANINI | 2023
Dans Clinical Toxicology (Vol.61, n°3, March 2023) Article : Périodique

Introduction: Illicit opioids, consisting largely of fentanyl, novel synthetic opioids, and adulterants, are the primary cause of drug overdose fatality in the United States. Xylazine, an alpha-2 adrenergic agonist and veterinary tranquilizer, i[...]

Plus d'info

Ajouter à la sélection

Lien externe

Tusi use among the New York City nightclub-attending population

J. J. PALAMAR ; N. ABUKAHOK ; P. ACOSTA ; A. J. KROTULSKI ; S. E. WALTON ; B. STANG ; C. M. CLELAND | 2025
Dans Addiction (Vol.120, n°8, August 2025) Article : Périodique

BACKGROUND AND AIMS: 'Tusi', also known as 'tusibí' or 'pink cocaine', is a drug concoction which previously emerged in Latin America and Europe and has recently acquired popularity in the United States (US). Consumers are often unaware that Tus[...]

Plus d'info

Ajouter à la sélection

Lien externe